Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel (JACC September 2018-2) is organized by American College of Cardiology (ACC).
Date of Release: September 10, 2018
Term of Approval/Date of CME/MOC/ECME Expiration: September 9, 2019
JACC Journal CME/MOC/ECME is intended for physicians who treat patients with cardiovascular disease.
Rheumatic heart disease (RHD) is a preventable heart condition that remains endemic among vulnerable groups in many countries. After a period of relative neglect, there has been are surging interest in RHD worldwide over the past decade. In this Scientific Expert Panel, we summarize recent advances in the science of RHD and sketch out priorities for current action and future research. We identify key questions for laboratory research into disease pathogenesis and epidemiological research on the burden of disease. We present a variety of pressing clinical research questions on optimal RHD prevention and advanced care. In addition, we propose a policy and implementation research agenda that can help translate current evidence into tangible action. We maintain that, despite knowledge gaps, there is sufficient evidence for national and global action on RHD, and we argue that RHD is model for strengthening health systems toaddress other cardiovascular diseases in limited-resource countries.
After reading this article the reader should be able to:
• Identify, within a global context, populations that remain at elevated risk of acute rheumatic fever and rheumatic heart disease.
• Summarize areas of consensus and the major gaps in evidence regarding the prevention and medical management of rheumatic heart disease.
• Describe indications for catheter-based or surgical management of common rheumatic valvular lesions.
Additional details will be posted as soon as they are available.